John Curnutte
Investor
San Francisco Bay Area
Overview
Work Experience
Board Member
2024 - Current
Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes.
Raised $250,000.00 from IndieBio, SOSV, SOSV and IndieBio.
Senior Advisor
2020
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.
SAB Member
2020
Autobahn Labs is a biotechnology company that accelerates the development of novel therapeutics.
Board of Directors Member
2017
Board Member
2019 - 2024
Consultant
2019 - 2020
Executive Vice President of Research & Development
2011 - 2019
Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.
Raised $1,314,100,015.00 from Athyrium Capital Management LP and HealthCare Royalty Partners.
CEO
2008 - 2010
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Raised $406,156,611.00 from Invus, Altium Capital, Rock Springs Capital, New Enterprise Associates, Ascletis, Huimei Capital, PFM Health Sciences and Kleiner Perkins.
President
2000 - 2008
Senior Director, Department of Immunology
1993 - 2000
Associate Professor (Tenured)
1986 - 1993
Education
M.D., Ph.D.
1973 - 1980
A.B.
1969 - 1973